Literature DB >> 22921882

The mesenchyme in malignancy: a partner in the initiation, progression and dissemination of cancer.

Mark A Glaire1, Emad M El-Omar, Timothy C Wang, Daniel L Worthley.   

Abstract

The tumor microenvironment presents an exciting opportunity for innovative prognostic and therapeutic approaches to human cancer. The diverse cellular and extracellular contribution to tumor growth argues that prevention and cure of human cancers will result only from a multifaceted approach to cancer therapy. In this review we provide a foundation for considering the mesenchymal contribution to the tumor microenvironment. We address normal mesenchymal development, physiological interactions between the epithelium and stroma and the cellular hierarchy within these compartments. We focus on cancer-associated fibroblasts in gastrointestinal malignancy but our models have also been informed by other tumor systems. The review provides a framework for characterizing the overall biological contribution of the mesenchyme to human disease. Understanding the biological heterogeneity of specific mesenchymal cells in cancer will provide new opportunities for targeted cancer prevention and therapy.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22921882     DOI: 10.1016/j.pharmthera.2012.08.007

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   13.400


  7 in total

1.  Helicobacter pylori-infected MSCs acquire a pro-inflammatory phenotype and induce human gastric cancer migration by promoting EMT in gastric cancer cells.

Authors:  Qiang Zhang; Juan Ding; Jinjun Liu; Wei Wang; Feng Zhang; Junhe Wang; Yuyun Li
Journal:  Oncol Lett       Date:  2015-11-10       Impact factor: 2.967

Review 2.  Bone marrow cells as precursors of the tumor stroma.

Authors:  Daniel L Worthley; Yiling Si; Michael Quante; Michael Churchill; Siddhartha Mukherjee; Timothy C Wang
Journal:  Exp Cell Res       Date:  2013-03-13       Impact factor: 3.905

Review 3.  Antidepressant fluoxetine and its potential against colon tumors.

Authors:  Helga Stopper; Sergio Britto Garcia; Ana Maria Waaga-Gasser; Vinicius Kannen
Journal:  World J Gastrointest Oncol       Date:  2014-01-15

4.  Reversal of gene dysregulation in cultured cytotrophoblasts reveals possible causes of preeclampsia.

Authors:  Yan Zhou; Matthew J Gormley; Nathan M Hunkapiller; Mirhan Kapidzic; Yana Stolyarov; Victoria Feng; Masakazu Nishida; Penelope M Drake; Katherine Bianco; Fei Wang; Michael T McMaster; Susan J Fisher
Journal:  J Clin Invest       Date:  2013-06-24       Impact factor: 14.808

5.  Loss of mesenchymal bone morphogenetic protein signaling leads to development of reactive stroma and initiation of the gastric neoplastic cascade.

Authors:  Sébastien A B Roy; Joannie M Allaire; Camille Ouellet; Faiza Maloum-Rami; Véronique Pomerleau; Étienne Lemieux; Jean-Philippe Babeu; Jasmin Rousseau; Marilène Paquet; Perrine Garde-Granger; François Boudreau; Nathalie Perreault
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

6.  Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer.

Authors:  Juan F Santibanez
Journal:  ISRN Dermatol       Date:  2013-07-18

7.  Registered report: Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.

Authors:  David Blum; Samuel LaBarge
Journal:  Elife       Date:  2014-12-10       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.